We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.30 | -1.36% | 21.70 | 21.50 | 22.00 | 21.75 | 21.75 | 21.75 | 713,708 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 56.04M | 16.12M | 0.0237 | 9.18 | 149.68M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/11/2024 16:02 | Is the 17 day static mean about to cross the 39 day volatile median, with 95% confidence? | lfdkmp | |
27/11/2024 13:46 | Share price down 10p in those 8 weeks | malcolmz1 | |
27/11/2024 13:45 | No prizes for longest holder of stock or member of chat room unfortunately. | malcolmz1 | |
27/11/2024 12:17 | It's nearly your 8 week anniversary on Advfn. 230 odd posts and no doubt all drivel....keep it up | kpe | |
27/11/2024 10:35 | Not sure about that. | malcolmz1 | |
27/11/2024 10:25 | Dare I say it but the bottom for the recent panic selling does seem to be in lol. - time for some panic buying | rachael777 | |
27/11/2024 10:11 | Here come the twitterati… Remember to share your winnings with the team | yump | |
27/11/2024 08:06 | Someone tell the sp | malcolmz1 | |
27/11/2024 07:27 | Hot off the press, Sounds busy at Hvivo's clinics! hxxps://youtu.be/Zgc | gotabsirius | |
26/11/2024 21:57 | Posters claiming to speak to IR. Look at TRMR, which was ramped by 1gw and his mates. Posters on there also claimed to speak to IR. They posted misleading info, which I found questionable. It turned out the posters were talking BS... | sikhthetech | |
26/11/2024 21:53 | Pogue, "Email from the company" Is it? Why have you not included the name, job title and company, the reply came from? So you emailed IR at IR@hvivo.com and someone from their PR company, Walbrook PR (Media & Investor Relations), who are independent and exist only to promote the company. That's what PR companies do, don't they? They wouldn't know what is happening within the company, the current situation and what the company is doing. The clue is it's a PR company who replied to you and not the company itself. PR companies exist to promote the company. The chairman knows the company better than any II, PI or PR company. Don't you agree? It's pulling wool over PIs eyes. IR email address: IR@hvivo.com Louis Ashe-Jepson works for Walbrook PR as indicated at bottom of their rns'. | sikhthetech | |
26/11/2024 16:48 | I also sent email and had same response, at least they know we're concerned. | tom218 | |
26/11/2024 16:20 | bought some more cheers pogue | manc10 | |
26/11/2024 14:58 | That's the same email that was sent out last week to a guy on the LSE forum. | chica1 | |
26/11/2024 14:40 | Thanks Pogue | pgaffney | |
26/11/2024 13:46 | Nothing to worry about other than the share price has been decimated and long term holders have seen their paper profits disappear just before Christmas. share price at same level as summer 2020. | malcolmz1 | |
26/11/2024 13:43 | The clue is in the name | malcolmz1 | |
26/11/2024 13:34 | Email from the company Thanks for your email. The company is of course aware of the recent share price weakness but is concentrated on factors within its control. hVIVO reiterated its guidance in September for £62 million in revenue with full year EBITDA margins anticipated to be at the upper end of market expectations for 2024, and there has been no change to this. If there are any material changes to expectations, the company would be required to issue an RNS to update the market. It is not in the company’s interest to make a habit of commenting on movements in share price or the decision-making of individual investors, for which there is a large number of contributing influences. It is in the nature of hVIVO’s business model for there to be gaps between contract announcements. Decisions on whether clients proceed with a challenge trial are complex and affected by a number of different factors outside of hVIVO’s control. The Company did announce in its interim results that it had a pipeline of live short to medium term opportunities of c. £40million. The company remains confident in the long-term growth of the business and human challenge trial market, and its medium term growth target of growing Group revenue to £100 million by 20 | pogue | |
26/11/2024 12:48 | Would it be madness to buy this FTSE stock smashed by Donald Trump’s team picks? | libertine | |
26/11/2024 12:48 | There you go, all as predicted months ago. My assertions have been consistent.. sikhthetech - 24 Sep 2024 - 12:28:52 - 8118 of 8805 hVIVO plc - HVO What will happen once Octopus buying eventually drys up? Sellers won't dry up and there will be those who can see the chairman dumped his entire holding at 28p & 29p, so that sets a ceiling for now. Sellers can also see that the CEO's >7m options are due to start exercise in just over 4 months time, what will happen when those options hit the market? Sellers can also see that revenue growth rate has slowed significantly and the . Where are the £40m of contracts the company mentioned months ago? If anything, the gang are selling down, whilst telling others to stay invested. Don't you think so, 1gw? After all you and your mates have a long history of doing so. | sikhthetech | |
26/11/2024 12:01 | This is sad to see. It happens all the time on AIM though. No sign of the selling stopping either. What are Octopus thinking I wonder? | malcolmz1 | |
26/11/2024 11:57 | Whatever the reasons for the fall, there needs to be some communication now from Mo. The silence is deafening. | hotteruk6 | |
26/11/2024 11:33 | Looks like sellers are in charge to me. Pi's cashing out, once bitten twice shy. We've seen this before.Disaster for long term sufferers. | malcolmz1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions